Page last updated: 2024-10-29

avapro and Endometrial Neoplasms

avapro has been researched along with Endometrial Neoplasms in 1 studies

Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.

Endometrial Neoplasms: Tumors or cancer of ENDOMETRIUM, the mucous lining of the UTERUS. These neoplasms can be benign or malignant. Their classification and grading are based on the various cell types and the percent of undifferentiated cells.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Lu, YU1
Miyamoto, T1
Takeuchi, H1
Tsunoda, F1
Tanaka, N1
Shiozawa, T1

Other Studies

1 other study available for avapro and Endometrial Neoplasms

ArticleYear
PPARĪ± activator irbesartan suppresses the proliferation of endometrial carcinoma cells via SREBP1 and ARID1A.
    Oncology research, 2023, Volume: 31, Issue:3

    Topics: Cell Proliferation; DNA-Binding Proteins; Endometrial Neoplasms; Female; Humans; Irbesartan; PPAR al

2023